Annexin Pharmaceuticals
Annexin advances phase IIa study by initiating patient treatment
Annexin Pharmaceuticals has taken an important step in its clinical development after the first two patients have now...
Bioteknik
Annexin Pharmaceuticals | Life Science Summit 2025
CEO Anders Haegerstrand presents Annexin Pharmaceuticals at Life...
Video
Annexin's Q3: Establishment of Medical Advisory Board and focus on ophthalmology
Annexin Pharmaceuticals has published its report for the...
Annexin Pharmaceuticals presents at Eyecelerator
Annexin strengthens operations with Medical Advisory Board
Annexin Pharmaceuticals has appointed a Medical Expert Council (Medical...
Bioteknik
Annexin appoints Medical Advisory Board in ophthalmology
Annexin Pharmaceuticals | Global Forum 2025
CEO Anders Haegerstrand presents Annexin Pharmaceuticals at BioStock...
Video
Annexin summarizes Q1: promising study data and fully subscribed issue
Annexin Pharmaceuticals has started 2025 with clear progress...
Intervju
News roundup Thursday, April 10
Implantica
Annexin Pharmaceuticals: “Then the market landscape will change completely”
Annexin Pharmaceuticals is currently conducting a rights issue that...
Intervju
Video
News roundup Friday, March 7
Kancera
News roundup Thursday, March 6
Cantargia